BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2659119)

  • 21. Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature.
    Hovenga S; de Wolf JT; Klip H; Vellenga E
    Bone Marrow Transplant; 1997 Nov; 20(10):901-4. PubMed ID: 9404934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T; Kojima S; Kato K
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of 4 patients with hematological malignancy treated with allogeneic bone marrow transplantation after conditioning including hyperfractionated total body irradiation].
    Kubo K; Naito K; Akao Y; Hiraiwa A; Naoe T; Yamada K; Matsunaga K; Kobayashi H; Matsuzaki M
    Rinsho Ketsueki; 1987 Jan; 28(1):40-6. PubMed ID: 3553647
    [No Abstract]   [Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
    Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
    Nomura N; Uchida H; Nakamura H; Shirota T; Sakai N; Ito H; Suzuki A; Otaka M; Kimura Y; Toyama K
    Transplant Proc; 1994 Aug; 26(4):2347. PubMed ID: 8066769
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful paternity of twins following bone marrow transplantation with busulfan, melphalan and cyclophosphamide conditioning.
    Shepherd JD; Hoar DI; Keown PA; Phillips GL
    Bone Marrow Transplant; 1996 Mar; 17(3):461-2. PubMed ID: 8704708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
    Castenskiold EC; Kelsey SM; Collins PW; Coldwell RD; Allen PD; Side LE; Makin HL; Goldstone AH; Newland AC
    Bone Marrow Transplant; 1995 Jun; 15(6):879-84. PubMed ID: 7581085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intensive chemotherapy followed by autologous bone marrow transplantation in solid tumors in childhood].
    de Kraker J; Voûte PA; Behrendt H
    Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2302-5. PubMed ID: 6392905
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
    Sureda A; Pérez de Oteyza J; García Laraña J; Odriozola J
    Sangre (Barc); 1989 Jun; 34(3):244. PubMed ID: 2762986
    [No Abstract]   [Full Text] [Related]  

  • 31. [Total body irradiation in hematology: clinical indications and prospects].
    Corvò R
    Recenti Prog Med; 1999 Nov; 90(11):601-4. PubMed ID: 10608150
    [No Abstract]   [Full Text] [Related]  

  • 32. [Multiple myeloma in 1990].
    Le Loët X; Monconduit M; Euller-Ziegler L
    Ann Med Interne (Paris); 1990; 141(2):108-10. PubMed ID: 2191611
    [No Abstract]   [Full Text] [Related]  

  • 33. [Case of plasmacytic leukemia with complete remission and 1-year survival after a combined 5-drug sequence therapy].
    Anisimowicz J; Mizan K
    Pol Tyg Lek; 1984 Sep; 39(36):1209-10. PubMed ID: 6504747
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
    Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
    Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete remission in plasma cell leukaemia.
    Krsnik I; Peñalver MA; Del Potro E; Diaz-Mediavilla J
    Br J Haematol; 1987 May; 66(1):145. PubMed ID: 3593651
    [No Abstract]   [Full Text] [Related]  

  • 36. Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.
    Avalos BR; Klein JL; Kapoor N; Copelan EA
    Bone Marrow Transplant; 1993 Dec; 12(6):655-8. PubMed ID: 8136749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
    Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
    Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.
    Landsburg DJ; Vogl DT; Plastaras JP; Stadtmauer EA
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e225-8. PubMed ID: 25172535
    [No Abstract]   [Full Text] [Related]  

  • 39. [Allogeneic bone marrow transplantation in the treatment of acute leukemias of children. Study of 26 patients].
    Michel G; Maraninchi D; Perrimond H; Mascret B; Orsini A; Gastaut JA; Raybaud C; Blaise D; Demeocq F; Sebahoun G
    Arch Fr Pediatr; 1986 Dec; 43(10):769-74. PubMed ID: 3548633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation.
    Conter V; D'Angelo P; Rizzari C; Jankovic M; Dampier C; Masera G; Johnson FL
    Bone Marrow Transplant; 1996 Feb; 17(2):287-9. PubMed ID: 8640182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.